Industry News
Pharmaceutical Industry News
Phony Diagnoses Hide High Rates of Drugging at Nursing Homes
At least 21 percent of nursing home residents are on antipsychotic drugs, a Times investigation found.
Unvaccinated Americans Are 11 Times More Likely to Die of Covid, C.D.C. Reports
Federal health officials released a handful of studies highlighting how effective the shots are at preventing infections, hospitalizations and deaths — even while the highly contagious Delta variant has been dominant.
Bausch pays whopping $300M to settle Glumetza pay-for-delay lawsuit after 800% price hike
Bausch pays whopping $300M to settle Glumetza pay-for-delay lawsuit after 800% price hike nhigginsdunn Fri, 09/10/2021 - 11:33
AstraZeneca chalks up double win for novel combo of asthma rescue inhaler
AstraZeneca chalks up double win for novel combo of asthma rescue inhaler aliu Fri, 09/10/2021 - 11:23
Pfizer snags world-first atopic dermatitis nod for Xeljanz follow-up Cibinqo amid FDA safety delay
Pfizer snags world-first atopic dermatitis nod for Xeljanz follow-up Cibinqo amid FDA safety delay aliu Fri, 09/10/2021 - 09:50
Amgen’s high-profile cancer med Lumakras set for rollout in England thanks to NHS access deal
Amgen's high-profile cancer med Lumakras set for rollout in England thanks to NHS access deal esagonowsky Fri, 09/10/2021 - 09:45
Hims & Hers drafts Super Bowl star Rob Gronkowski to drive men’s health awareness
Hims & Hers drafts Super Bowl star Rob Gronkowski to drive men's health awareness bbulik Fri, 09/10/2021 - 09:28
Fierce Pharma Asia—Takeda’s AbbVie drug supply lawsuit, Novavax’ COVID vaccine deal; Juno, WuXi’s CAR-T nod
Fierce Pharma Asia—Takeda's AbbVie drug supply lawsuit, Novavax' COVID vaccine deal; Juno, WuXi's CAR-T nod aliu Fri, 09/10/2021 - 05:53
Despite mixed phase 3 showing, Apellis hopes to push eye disorder drug past FDA’s finish line
Despite mixed phase 3 showing, Apellis hopes to push eye disorder drug past FDA's finish line nhigginsdunn Thu, 09/09/2021 - 15:34
Biogen CEO blames Aduhelm’s rocky launch on ‘too much confusion, misinformation and controversy’
Biogen CEO blames Aduhelm’s rocky launch on 'too much confusion, misinformation and controversy' esagonowsky Thu, 09/09/2021 - 14:20
Biden Administration Goes Bigger on Cutting Drug Prices
The administration endorses a proposal for the government to negotiate on prices for all U.S. purchasers, not just Medicare.
Tossing same-old pharma marketing, agency veteran turns to Clubhouse and digital health democracy for inspiration
Tossing same-old pharma marketing, agency veteran turns to Clubhouse and digital health democracy for inspiration bbulik Thu, 09/09/2021 - 13:06
Acorda slashes jobs again as generics hamper sales of MS drug
Acorda slashes jobs again as generics hamper sales of MS drug klahucik Thu, 09/09/2021 - 11:47
Perrigo dishes out $2.1B for HRA Pharma, a big step on its quest to become self-care heavyweight
Perrigo dishes out $2.1B for HRA Pharma, a big step on its quest to become self-care heavyweight nhigginsdunn Thu, 09/09/2021 - 11:37
WCLC: Jazz charts new path for small cell lung cancer drug Zepzelca after late-stage flop
WCLC: Jazz charts new path for small cell lung cancer drug Zepzelca after late-stage flop aliu Thu, 09/09/2021 - 10:50
No dice: Court tells AbbVie it can’t force Takeda to supply a drug that’s in shortage worldwide
No dice: Court tells AbbVie it can't force Takeda to supply a drug that's in shortage worldwide esagonowsky Thu, 09/09/2021 - 10:33
AstraZeneca’s COVID-19 shot joins the list of vaccines flagged for rare Guillain-Barre syndrome
AstraZeneca's COVID-19 shot joins the list of vaccines flagged for rare Guillain-Barre syndrome kdunleavy Thu, 09/09/2021 - 09:43
Responding to COVID-19 and biologic demands, DuPont adds capacity at silicone business Liveo
Responding to COVID-19 and biologic demands, DuPont adds capacity at silicone business Liveo esagonowsky Thu, 09/09/2021 - 09:15
WCLC: AstraZeneca’s detailed Imfinzi, tremelimumab data in metastatic NSCLC are far from a clear-cut win
WCLC: AstraZeneca's detailed Imfinzi, tremelimumab data in metastatic NSCLC are far from a clear-cut win aliu Thu, 09/09/2021 - 08:07
Genome of South Korea gains CDMO capability and drug material insurance with $27M purchase of List Labs
Genome of South Korea gains CDMO capability and drug material insurance with $27M purchase of List Labs kdunleavy Wed, 09/08/2021 - 23:50